CN Bio, which provides Organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows, ...

Cambridge biotech company Shift Bioscience, which is using an AI powered virtual cell to fight age-driven diseases, has ...

Pioneering biotech Maxion Therapeutics has more than doubled its footprint at Howard Group's Unity Campus in Cambridge.

A superchip superstar has taken the CEO role at the exciting Cambridge open silicon ecosystem organisation lowRISC C.I.C. Javier Orensanz Martinez takes the reins on June 2 with more than two decades ...

Type 1 diabetes sufferers in the UK and certain other locations in Europe can now manage their condition directly from the iPhone thanks to Cambridge innovation. University of Cambridge spin-out ...

Carbon13 in Cambridge has struck a fresh blow for ClimateTech by investing £1.2 million into an exciting array of sustainable ...

Cambridge life science company CellCentric has raised $120 million Series C financing to advance its fight against an ...

Cambridge life science game-changer ViaNautis has long caught the eye as one of the sector's most exciting companies and ...

Ventures Tour featuring a range of portfolio pitch sessions hosted by some of Cambridge’s most prominent venture capital ...

Wooing next generation talent is a keynote feature of Cambridge Tech Week in September. CTW's Tech Futures initiative is ...

Arecor Therapeutics plc, an AIM-quoted life science company based in Cambridge, has agreed a significant formulation ...

Vellos – a company founded by the Director of the Milner Therapeutics Institute at the University of Cambridge , Professor Sir Tony Kouzarides – has announced a new partnership with Fifty Years, a ...